TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04789616 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT05850286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05850286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05850286 — Predictive Biomarker (PRD): TP53INP2 mRNA
Genes: TP53INP2; C20orf110; DOR; PINH
Study NCT06277011 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05057819 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06451705 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05981209 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05981209 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05981209 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT04949516 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05538377 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05209256 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06201000 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04907877 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06585644 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06253195 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06253195 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06253195 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06253195 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05189418 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05432635 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05766371 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06093893 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06322589 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05986851 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06229340 — Safety Biomarker (SAF): RAS pathway
Study NCT04566120 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04293224 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05914792 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05914792 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06180499 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study NCT06061263 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05944068 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06544226 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06506630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05431608 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT05431608 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05943379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05031065 — Predictive Biomarker (PRD): ENPP2 mRNA
Genes: ENPP2; ATX; PDNP2
Study NCT06051721 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06270199 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05925751 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05333133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06719973 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT06720324 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05888103 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05888103 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05487300 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06721910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05634785 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06194565 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05360381 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06652178 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05007418 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05827328 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05199636 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05199636 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06652412 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT06652412 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05491837 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06129422 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MUC5AC mRNA
Genes: MUC5AC; MUC5
Study NCT06190249 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06561412 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06561412 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05230446 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT04696809 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06027424 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05256836 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04285671 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06025903 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05387785 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT04047355 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05153603 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05262660 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06493448 — Predictive Biomarker (PRD): GCLM mRNA
Genes: GCLM; GLCLR
Study NCT06256484 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06538870 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06505252 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05850858 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05850858 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT06558565 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05700851 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05124028 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05000593 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05551273 — Predictive Biomarker (PRD): TLR8 mRNA
Genes: TLR8; UNQ249/PRO286
Study NCT06126315 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT06126315 — Predictive Biomarker (PRD): PPIA mRNA
Genes: PPIA; CYPA
Study NCT06126315 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06126315 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06126315 — Safety Biomarker (SAF): miR-206
Genes: MIR206
Study NCT06126315 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT06126315 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT06628180 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06720220 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT06720272 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT05262244 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06096506 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06096506 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05982847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06261567 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT05108428 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05655260 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06442969 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05364073 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05364073 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05364073 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05081167 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT06326008 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06326008 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04734015 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04711044 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study NCT05174260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05069597 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05438511 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05910879 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04430673 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05795283 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05795283 — Safety Biomarker (SAF): BDNF
Study NCT06181123 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05159726 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05159687 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT05159687 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT05159687 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study NCT05159687 — Predictive Biomarker (PRD): SLC6A2 mRNA
Genes: SLC6A2; NAT1; NET1; SLC6A5
Study NCT00002004 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05963282 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05487209 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04764097 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05657080 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Trefoil factor 3
Genes: TFF3; ITF; TFI
Study NCT06516146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06125184 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT06125184 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00002297 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05228808 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04975386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05973500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05544357 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06433869 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06433869 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05809284 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00194961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00194961 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04056910 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05499312 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05350111 — Predictive Biomarker (PRD): CAMP mRNA
Genes: CAMP; CAP18; FALL39; HSD26
Study NCT04067115 — Predictive Biomarker (PRD): FLI1 mRNA
Genes: FLI1
Study NCT05849389 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT05849389 — Surrogate Endpoint (SUR): Annualized growth velocity
Study NCT04739319 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05351762 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06334783 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05420077 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02968953 — Predictive Biomarker (PRD): SLC2A1 mRNA
Genes: SLC2A1; GLUT1
Study NCT05571540 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05116579 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05061771 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05065632 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05268900 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05083962 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05303636 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00433095 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04916340 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06206616 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT05955729 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05832320 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study NCT05533814 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT05270889 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05208255 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT06088082 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05988385 — Predictive Biomarker (PRD): OAT mRNA
Genes: OAT
Study NCT06602362 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06106308 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06106308 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06716970 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06716281 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06448546 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05541172 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05746676 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04994418 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00050518 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05985577 — Predictive Biomarker (PRD): PRDX2 mRNA
Genes: PRDX2; NKEFB; TDPX1
Study NCT05985577 — Predictive Biomarker (PRD): DDX27 mRNA
Genes: DDX27; cPERP-F; RHLP; HSPC259; PP3241
Study NCT05989763 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT06504043 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04655391 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04655391 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06156488 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06013865 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05711953 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04951999 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06167512 — Predictive Biomarker (PRD): HK2 mRNA
Genes: HK2
Study NCT06167512 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT06167512 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT06167512 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study NCT05163600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05933395 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05933395 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05908513 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05241106 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05773963 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04907656 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT06219174 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT06134648 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06198868 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06636773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06499155 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06549270 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study NCT06549270 — Safety Biomarker (SAF): miR-30a
Genes: MIR30A
Study NCT06549270 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT06585059 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05119205 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04758780 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT05755048 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00001105 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05187715 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05130177 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06462768 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04916847 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04952402 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05695898 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05695898 — Predictive Biomarker (PRD): ICOS mRNA
Genes: ICOS; AILIM
Study NCT05695898 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT05606094 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05467267 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT02438202 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT02438202 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02438202 — Safety Biomarker (SAF): BDNF
Study NCT05376124 — Predictive Biomarker (PRD): ETV1 mRNA
Genes: ETV1; ER81
Study NCT05376124 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06504901 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06126471 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT05813145 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT05813145 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT06033001 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05194592 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05194592 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04859023 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06043089 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05274971 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05175430 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT03541889 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03541889 — Predictive Biomarker (PRD): TK1 mRNA
Genes: TK1
Study NCT06176690 — Pharmacodynamic Biomarker (PDY): Interleukin 7 receptor alpha
Genes: IL7R
Study NCT06176690 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05188690 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06210178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06254586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04155112 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05380804 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT05823961 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04967833 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06208033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04838613 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06431490 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05765240 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06219512 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05077397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04693234 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT02588807 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05666492 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04984798 — Safety Biomarker (SAF): Glutamate dehydrogenase
Study NCT05484739 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05313594 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06020495 — Surrogate Endpoint (SUR): Serum sodium
Study NCT05924295 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT05951790 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05253053 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT04194671 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05316753 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT05885607 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05779098 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05779098 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study NCT05033158 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06001476 — Predictive Biomarker (PRD): STK11 mRNA
Genes: STK11; LKB1; PJS
Study NCT05673512 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05409456 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06384040 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14